The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107298506 10729850 6 F 201601 20160321 20150122 20160331 EXP CA-GLAXOSMITHKLINE-CA2014GSK008203 GLAXOSMITHKLINE 63.09 YR F Y 0.00000 20160331 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107298506 10729850 1 PS BENLYSTA BELIMUMAB 1 Intravenous (not otherwise specified) 1270 MG, Z 125370 1270 MG
107298506 10729850 2 SS BENLYSTA BELIMUMAB 1 Intravenous (not otherwise specified) 1250 MG, Z 125370 1250 MG
107298506 10729850 3 SS BENLYSTA BELIMUMAB 1 Intravenous (not otherwise specified) 1270 MG, UNK 125370 1270 MG
107298506 10729850 4 SS BENLYSTA BELIMUMAB 1 Intravenous (not otherwise specified) 1300 MG, UNK 125370 1300 MG
107298506 10729850 5 C PREDNISONE. PREDNISONE 1 10 MG, UNK 0 10 MG TABLET
107298506 10729850 6 C LANZOPRAL 2 UNK 0
107298506 10729850 7 C FUROSEMIDE. FUROSEMIDE 1 20 MG, UNK 0 20 MG
107298506 10729850 8 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 20 MG, UNK 0 20 MG
107298506 10729850 9 C PREGABALIN. PREGABALIN 1 UNK 0
107298506 10729850 10 C BUPROPION XL BUPROPION 1 150 MG, UNK 0 150 MG
107298506 10729850 11 C TELMISARTAN. TELMISARTAN 1 40 MG, UNK 0 40 MG
107298506 10729850 12 C FERROUS SULFATE FERROUS SULFATEFERROUS SULFATE, DRIED 1 UNK 0
107298506 10729850 13 C HYDROXYQUINOLINE 2 20 MG, UNK 0 20 MG
107298506 10729850 14 C EURO-K 2 1500 MG, UNK 0 1500 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107298506 10729850 1 Systemic lupus erythematosus
107298506 10729850 5 Product used for unknown indication
107298506 10729850 6 Product used for unknown indication
107298506 10729850 7 Product used for unknown indication
107298506 10729850 8 Product used for unknown indication
107298506 10729850 9 Product used for unknown indication
107298506 10729850 10 Product used for unknown indication
107298506 10729850 11 Product used for unknown indication
107298506 10729850 12 Anaemia
107298506 10729850 13 Product used for unknown indication
107298506 10729850 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
107298506 10729850 OT
107298506 10729850 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
107298506 10729850 Bronchitis
107298506 10729850 Cough
107298506 10729850 Drug dose omission
107298506 10729850 Hospitalisation
107298506 10729850 Influenza
107298506 10729850 Nonspecific reaction
107298506 10729850 Pneumonia
107298506 10729850 Sinusitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
107298506 10729850 1 20130404 0
107298506 10729850 2 20130404 0
107298506 10729850 3 20160107 0
107298506 10729850 4 20160224 0